Hints and tips:
Related Special Reports
...“Own your conversation around health, or someone else will.”...
...Europe’s most valuable company with a market capitalisation of DKr4.1tn ($602.7bn) also said it expected China to approve Wegovy for sale later in 2024....
...However, Schweizer said the consulting market “feels more positive” this year, adding that BCG’s sales were growing “in the teens again” percentage-wise, during the first quarter of 2024....
...J&J was valued at $367bn, as of market close in New York on Thursday....
...Concerns over an additional FDA review of donanemab could give Eisai a chance to win greater market share....
...The jab was late to market and suffered from collapsing demand as governments withdrew from procurement deals. The group had a market value of $600mn, as of market close on Friday....
...Pfizer and BioNTech will dispute Moderna’s ability to withdraw the pledge when it did, given the World Health Organization did not declare the end of the “global health emergency” until March 2023....
...Bulls can point to signs of improving health....
...Then, GLP-1 anti-obesity drugs hit the market, long-time spokesperson and board member Oprah Winfrey announced her departure, and the company’s credit rating was downgraded....
...A great part of the current and projected growth of the industry derives from how comprehensively sleep, and the lack of it, are entwined in the broader discourse of health and the prevention of disease....
...Tesla shareholders are bracing for the carmaker’s worst earnings performance in seven years, oil markets have remained steady as Middle East tensions rise, and China’s first-quarter GDP shows the effects...
...“We’re positioning the company for the long-term health of the business and the market doesn’t necessarily operate that way,” she said....
...London market is a scapegoat for poor performance When a UK company’s share price goes south, simply blame the London market....
...US healthcare stocks featured heavily among Wall Street’s worst performers after the White House’s payment rate to private Medicare plans came in below market expectations....
...Bond markets have always been a pedantic person’s playground....
...The UK Medicines and Healthcare Regulatory Agency (MHRA) has also struggled to approve drugs at the same rate as the EU, making it difficult for makers of generic medicines to enter the UK market....
...TikTok is gearing up for a long legal battle against legislation in the US that threatens to ban the app in its largest market if its Chinese owner ByteDance refuses to sell the viral video platform....
...Nomura reckons they could take a fifth of the market by 2033. Currently there are more than 100 GLP-1 pipeline drugs under development. These locally-made drugs are not far off hitting the market....
...For that reason, the 2023 FT Person of the Year went to Lars Fruergaard Jørgensen, chief executive of Novo Nordisk, the pharmaceutical company that brought these successful weight-loss drugs to market....
...Deaths from the condition have fallen in most high-income states over the past 30 years, partly reflecting public health campaigns and increased testing....
...Crevoiserat: We love a competitive market, and we’re performing....
...I’ve got another meeting with Wes Streeting and Peter Kyle about AI in the health service tomorrow. Feel like I am making headway....
...Regulators in Europe and other countries including the US have been scrutinising more deals after accusations they had been too lax about relatively small transactions with potential for significant market...
...The booming weight loss drug market — which is expected to be worth $100bn by the end of the decade — is dominated by those two rivals....
International Edition